New Key Statistics Module, Z-Score and F-Score
NAS:ABUS Key Ratios
| Market Cap $ M | 488.27 |
| Enterprise Value $ M | 364.04 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 4.34 |
| Price/Sales | 24.64 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 18.00 |
| EPS (TTM) $ | -0.44 |
| Beneish M-Score | -1.44 |
| 10-y EBITDA Growth Rate % | 13.10 |
| 5-y EBITDA Growth Rate % | 25.90 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -5.03 |
| EV-to-EBITDA | -5.13 |
| PEG | -- |
| Shares Outstanding M | 180.17 |
| Net Margin (%) | -401.57 |
| Operating Margin % | -430.15 |
| Pre-tax Margin (%) | -401.57 |
| Quick Ratio | 5.87 |
| Current Ratio | 5.87 |
| ROA % (ttm) | -42.04 |
| ROE % (ttm) | -56.84 |
| ROIC % (ttm) | -192.33 |
| Dividend Yield % | -- |
| Altman Z-Score | -5.36 |
ABUS Number of Guru Trades
ABUS Volume of Guru Trades
Gurus Latest Trades with NAS:ABUS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:ABUS is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Arbutus Biopharma Corp Insider Transactions
No Available Data
News about NAS:ABUS
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers